DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Phase I - Functionalization of compounds	R-HSA-211945	0	Tretinoin	444795	pubchem
Cytochrome P450 - arranged by substrate type	R-HSA-211897	0	Tretinoin	444795	pubchem
Vitamins	R-HSA-211916	0	Tretinoin	444795	pubchem
Miscellaneous substrates	R-HSA-211958	0	Tretinoin	444795	pubchem
Signaling Pathways	R-HSA-9824443	0	Tretinoin	444795	pubchem
Signaling by Nuclear Receptors	R-HSA-9006931	0	Tretinoin	444795	pubchem
Signaling by Retinoic Acid	R-HSA-5362517	0	Tretinoin	444795	pubchem
RA biosynthesis pathway	R-HSA-5365859	0	Tretinoin	444795	pubchem
Disease	R-HSA-1643685	0	Tretinoin	444795	pubchem
Diseases of metabolism	R-HSA-5668914	0	Tretinoin	444795	pubchem
Metabolic disorders of biological oxidation enzymes	0	0	Tretinoin	444795	pubchem
Defective CYP26B1 causes RHFCA	R-HSA-5579015	0	Tretinoin	444795	pubchem
Gene expression	#N/A	#N/A	Tretinoin	444795	pubchem
RNA Polymerase II Transcription	R-HSA-73857	0	Tretinoin	444795	pubchem
Generic Transcription Pathway	R-HSA-212436	0	Tretinoin	444795	pubchem
Transcriptional regulation by the AP-2 family of transcription factors	0	0	Tretinoin	444795	pubchem
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	0	0	Tretinoin	444795	pubchem
Cardiac progenitor differentiation	R-HSA-5576891	0	Tretinoin	444795	pubchem
Pluripotent stem cell differentiation pathway	R-HSA-452723	0	Tretinoin	444795	pubchem
Dopaminergic neurogenesis	R-HSA-9675108	0	Tretinoin	444795	pubchem